102
Participants
Start Date
January 31, 2024
Primary Completion Date
July 31, 2024
Study Completion Date
December 31, 2024
JMT101
JMT101, 6 mg/kg, IV infusion once every two weeks (one treatment cycle is 4 weeks).
SG001
240 mg, IV infusion once every two weeks (one treatment cycle is 4 weeks).
Irinotecan
180mg/m\^2, IV infusion once every two weeks (one treatment cycle is 4 weeks).
Regorafenib (Stivarga)
160 mg, taken orally once daily for the first 21 days of each 28-day cycle.
Shanghai JMT-Bio Inc.
INDUSTRY